Gregory Steinberg
McMaster University, ON, Canada
- This delegate is presenting an abstract at this event.
Dr. Steinberg is a professor of medicine at McMaster University where he holds a Tier 1 Canada Research Chair and a J. Bruce Duncan Endowed Chair in Metabolic Diseases and is Co-Director of the Centre for Metabolism, Obesity and Diabetes Research.
Greg completed his PhD in 2002 at the University of Guelph studying muscle metabolism. He then conducted postdoctoral research for 5 years at the University of Melbourne in molecular biology and protein biochemistry. In 2008, he returned to Canada as an Associate Professor in the Department of Medicine at McMaster University.
His research studies cellular energy sensing mechanisms and how endocrine factors, lipid metabolism and insulin sensitivity are linked and contribute to the development of obesity, NAFLD/NASH, type 2 diabetes, cardiovascular disease and cancer. He has published over 220 papers and since 2020 has made the list of the world’s most highly cited researchers. Importantly, many of these studies have laid the foundation for therapies that have recently been approved or are in clinical trials for liver disease or cardiovascular disease.
His scientific contributions have been recognized by the Endocrine Society, Diabetes Canada, the Canadian Institutes of Health Research and the American Diabetes Association who have presented him with outstanding/early career scientific achievement awards.
Presentations this author is a contributor to:
Excitatory neuron-specific repression of AMPKβ2 impairs recognition memory, synaptic morphology, and hippocampal LTP in mice. (#36)
11:50 AM
Nathaniel Swift
4.2 New tools/Directions I
AMPK inhibition of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) (#34)
9:50 AM
Gregory Steinberg
4.1 AMPK in Metabolism II